about
Phosphoinositol lipids bind to phosphatidylinositol 3 (PI3)-kinase enhancer GTPase and mediate its stimulatory effect on PI3-kinase and Akt signalingsDysregulated TCL1 promotes multiple classes of mature B cell lymphoma.Therapeutic Implications of Targeting AKT Signaling in MelanomaTORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformationCurrent status of human chromosome 14T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma linesIdentification, characterization and metagenome analysis of oocyte-specific genes organized in clusters in the mouse genomeAberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development?TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemiaLysosomal interaction of Akt with Phafin2: a critical step in the induction of autophagySp1 transactivation of the TCL1 oncogeneArgBP2gamma interacts with Akt and p21-activated kinase-1 and promotes cell survivalPIKE (phosphatidylinositol 3-kinase enhancer)-A GTPase stimulates Akt activity and mediates cellular invasionBSTA promotes mTORC2-mediated phosphorylation of Akt1 to suppress expression of FoxC2 and stimulate adipocyte differentiationMosaic loss of chromosome Y is associated with common variation near TCL1ARas GTPase-activating protein binds to Akt and is required for its activationTCL1 participates in early embryonic development and is overexpressed in human seminomasProtooncogene TCL1b functions as an Akt kinase co-activator that exhibits oncogenic potency in vivo.Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/protein kinase B isoforms in insulin actions.Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data.Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies.The TCL1A oncoprotein interacts directly with the NF-kappaB inhibitor IkappaB.GT1b-induced neurotoxicity is mediated by the Akt/GSK-3/tau signaling pathway but not caspase-3 in mesencephalic dopaminergic neuronsNovel inhibitors of AKT: assessment of a different approach targeting the pleckstrin homology domain.Maternal effect genes: Findings and effects on mouse embryo development.Identification of nerve growth factor-responsive element of the TCL1 promoter as a novel negative regulatory element.Identification of small proline-rich repeat protein 3 as a novel atheroprotective factor that promotes adaptive Akt signaling in vascular smooth muscle cells.New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapiesAkt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer.MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype.EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cellsThe miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury.Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL)Interplay between HIV-1 infection and host microRNAs.Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injuryTCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas.The TCL1 family of oncoproteins: co-activators of transformation.Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression
P2860
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
P248
Q24537693-245E2CDF-B16D-44C3-88CB-FE70DC78831BQ24540383-21AED322-EC66-4658-832C-4745F5D5367DQ24631438-E5BFDEAB-2072-4358-8B61-2D3DB7C057C5Q24674168-C7605210-083D-414B-A76B-92EBA49C10DDQ24679620-0AE314EC-C88B-4160-8BF2-68F2530E87F4Q24681203-3D02C215-23BA-41F0-B3AF-85811CFD3E1CQ24814629-4CB51B0E-73BF-492F-AEEC-A32C9F9AE3E9Q26738706-12276034-92F9-4199-A46F-1D0A1E7935A0Q26773053-026F9318-1C19-456C-A2EB-FAC374365083Q27302379-B4374394-1D29-48D7-8318-E8D9CB249A40Q28214220-4886690C-AD4A-4946-9228-FE2BB86D06D8Q28241283-1FE27777-436A-49F5-80BF-F0B64158BE65Q28242382-56CC23DE-567C-4DB7-AF32-5859E21B6667Q28282926-8B9A58E3-C221-4E39-8C5C-BEE45F833F06Q28393244-4B06079D-832A-4B55-8362-1C9AFDA4F398Q28580317-5DD40C90-4735-4910-AED7-833FD463CCE8Q28584959-1C9A821E-9CAB-4288-8912-8C56BA96A2CFQ30556645-7858065C-17AA-4E68-AA85-C1471A78F239Q30811594-C4F3F5D7-A0FA-4886-B7F2-CD203AD158CFQ30925087-B61C5D0F-D0F5-4A34-9B85-2DAC0E2BBAB4Q30985619-60598521-5AE4-48F4-ABF1-7AEDF4F2DA6FQ31040364-D26B4E11-68A5-4226-B7B0-35CC8A3FA80EQ33492280-C0F4638B-8F1A-4F43-97E4-E85ED276209FQ33602001-7D45E057-E4FD-4A2F-AE49-9F291F28A0C4Q33882138-C07119EC-31BC-4597-B6E0-6632055B1303Q33917087-575E325D-6932-4E7D-B3B1-F02BD487B46CQ34546650-866BCD6E-8F28-46C3-B276-4260CE8DB2EFQ34550490-F5FCD612-91E9-4C4E-B93F-EABE79FD2F69Q34683488-CEFB8364-E295-4478-9C9A-2053A706C918Q35445077-B4429115-555C-44DE-BF71-7D4255489E57Q35553338-9D316886-7F24-46EC-8ED3-2223CDA26B6AQ35784734-EE313BC3-33A7-43F8-A559-D982C1F9FA3AQ35786347-4962760E-C610-44A9-A141-B100DBB6EBA5Q35787000-07FACD69-C557-40FC-A3D7-4DF4F810F1A3Q35823730-ADAA8961-7943-4234-9EAC-410493D5A9F0Q35849088-1B27841C-C4A4-4268-9D23-01AD91063FB9Q35971676-209A2717-99A6-49F5-BCBB-30F13AED2E65Q36194235-AD9BD030-6387-4138-ABC7-DC5DCC394D30Q36213981-885A49EE-A4B2-409F-8E01-1C2060B45965Q36245513-60CB988F-BFBE-4BD5-BB6F-C7EF4F7F4347
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The protooncogene TCL1 is an Akt kinase coactivator
@ast
The protooncogene TCL1 is an Akt kinase coactivator
@en
The protooncogene TCL1 is an Akt kinase coactivator
@nl
type
label
The protooncogene TCL1 is an Akt kinase coactivator
@ast
The protooncogene TCL1 is an Akt kinase coactivator
@en
The protooncogene TCL1 is an Akt kinase coactivator
@nl
prefLabel
The protooncogene TCL1 is an Akt kinase coactivator
@ast
The protooncogene TCL1 is an Akt kinase coactivator
@en
The protooncogene TCL1 is an Akt kinase coactivator
@nl
P2093
P921
P3181
P1433
P1476
The protooncogene TCL1 is an Akt kinase coactivator
@en
P2093
P304
P3181
P356
10.1016/S1097-2765(00)00039-3
P407
P577
2000-08-01T00:00:00Z